对华法林-果相互作用的代谢洞察力:一个试点研究整合了临床观察和代谢学
Piyapat Rattanasuwan1, Prem Lertpongpipat1, Natthapat Hiranchatchawal1
1Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
ADMET & DMPK
|June 30, 2025
概括
果的消费可能会通过影响甘3-酸盐水平来提高华法林的抗凝剂作用,可能会损害糖解和血小板功能. 这一发现为个性化的华法林管理提供了对药物与食品相互作用的见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 华法林是一种关键的抗凝剂,具有狭窄的治疗范围,易受药物相互作用的影响.
- 升高的国际规范化比率 (INR) 和超治疗性抗凝剂是与华法林相关的风险,特别是在药物与食品相互作用方面.
- 以前的报道将果消费与INR增加联系起来,但分子机制尚不清楚.
研究的目的:
- 为了研究华法林和果之间的相互作用的分子基础.
- 阐明在华法林治疗患者的果消费后与INR升高相关的代谢变化.
主要方法:
- 利用基于质子核磁共振 (1H-NMR) 的代谢学.
- 采用了一项前后设计研究,涉及从接受华法林治疗的患者收集血样本.
- 在果消费前后收集样本,并在INR恢复到治疗范围后的洗期后收集样本.
主要成果:
- 在华法林治疗期间食用果的患者中发现了甘3-酸盐的减少.
- 观察到血糖分解受损和血小板激活受损,可能与降低的甘3-酸盐有关.
- 证明了这些代谢变化与INR水平升高之间的相关性.
结论:
- 这项研究提供了对华法林-果相互作用的第一个1H-NMR代谢学的见解.
- 降低的甘3-酸盐可能是导致果消费后INR升高的关键代谢物.
- 1H-NMR代谢学可以阐明药物与食物之间的相互作用,有助于个性化抗凝剂治疗和患者安全.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:19Factors Affecting Drug Biotransformation: Biological
254
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
254
01:40Overview of Metabolism
32.1K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
32.1K
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
200
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
200
01:12Analysis of Population Pharmacokinetic Data
396
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
396
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
131
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
131